Mouse Models of Human Familial Cancer Syndromes

Toxicologic Pathology

Volumn 32, Issue SUPPL. 1, 2004, Pages 90-98

  Ward, Jerrold M ^a,b   Devor Henneman, Deborah E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cancer; Genetics; Heritable; Mice; Models

Indexed keywords

ANIMAL MODEL; ATM GENE; BLM GENE; BREAST CANCER; CANCER THERAPY; ENDOCRINE TUMOR; FAMILIAL CANCER; GASTROINTESTINAL TUMOR; GENE INTERACTION; GENETIC DISORDER; GENETIC ENGINEERING; GENETICALLY ENGINEERED MOUSE; HUMAN; KIDNEY TUMOR; LEUKEMIA; LKB1 GENE; LYMPHOMA; MEDICAL RESEARCH; MEN1 GENE; MLH GENE; MOLECULAR BIOLOGY; MOUSE; MSH GENE; NERVOUS SYSTEM TUMOR; NF1 GENE; NONHUMAN; ONCOGENE; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN INTERACTION; PTEN GENE; RB1 GENE; REVIEW; SKIN TUMOR; TP53 GENE; TRANSGENIC MOUSE; TSC1 GENE; TSC2 GENE; TUMOR MODEL; TUMOR SUPPRESSOR GENE; VHL GENE; XPA GENE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; SYNDROME;

ANIMALIA; MUS MUSCULUS;

EID: 1842615074     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1080/01926230490424680     Document Type: Review

References (105)

1. Bardeesy, N., Sinha, M., Hezel, A. F., Signoretti, S., Hathaway, N. A., Sharpless, N. E., Loda, M., Carrasco, D. R., and DePinho, R. A. (2002). Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 419, 162-7.
2. Barlow, C., Hirotsune, S., Paylor, R., Liyanage, M., Eckhaus, M., Collins, F., Shiloh, Y., Crawley, J. N., Ried, T., Tagle, D., and Wynshaw-Boris, A. (1996). Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86, 159-71.
3. Berg, R. J. W., de Vries, A., van Steeg, H., and de Gruijl, F. R. (1997). Relative susceptibilities of XPA knockout mice and their heterozygous and wild-type littermates to UVB-induced skin cancer. Cancer Res 57, 581-4.
4. Blachford, S. L. (ed). (2002). The Gale Encyclopedia of Genetic Disorders. Detroit, Gale Group, 1345 p.
5. Brannan, C. I., Perkins, A. S., Vogel, K. S., Ratner, N., Norlund, M. L., Reid, S. W., Buchberg, A. M., Jenkins, N. A., Parada, L. F., and Copeland, N. G. (1994). Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev 8, 1019-29.
6. Cai, S., Everitt, J. I., Kugo, H., Cook, J., Kleymenova, E., and Walker, C. L. (2003). Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development. Am J Pathol 162, 457-68.
7. Cheung, A. M., Hande, M. P., Jalali, F., Tsao, M-S., Skinnider, B., Hirao, A., McPherson, J. P., Karaskova, J., Suzuki, A., Wakeham, A., You-Ten, A., Elia, A., Squire, J., Bristow, R., Hakem, R., and Mak, T. W. (2002). Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis. Cancer Res 62, 6194-204.
8. Chester, N., Kuo, F., Kozak, C., O'Hara, C. D., and Leder, P. (1998). Stage-specific apoptosis, developmental delay, and embryonic lethality in mice homozygous for a targeted disruption in the murine Bloom's syndrome gene. Genes Dev 12, 3382-93.
9. Choyke, P. L., Glenn, G. M., Walther, M. M., Zbar, B., and Linehan, W. M. (2003). Hereditary renal cancers. Radiology 226, 33-46.
10. Cichowski, K., Shih, T. S., Schmitt, E., Santiago, S., Reilly, K., McLaughlin, M. E., Bronson, R. T., and Jacks, T. (1999). Mouse models of tumor development in neurofibromatosis Type 1. Science 286, 2172-6.
11. Classon, M., and Harlow, E. (2002). The retinoblastoma tumour suppressor in development and cancer. Nature 2, 910-7.
12. Crabtree, J. S., Scacheri, P. C., Ward, J. M., Garrett-Beal, L., Emmert-Buck, M. R., Edgemon, K. A., Lorang, D., Libutti, S. K., Chandrasekharappa, S. C., Marx, S. J., Spiegel, A. M., and Collins, F. S. (2001). A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98, 1118-23.
13. Crabtree, J. S., Scacheri, P. C., Ward, J. M., McNally, S. R., Swain, G. P., Montagna, C., Hager, J., Hanahan, D., Edlund, H., Magnuson, M. A., Garrett-Beal, L., Burns, A. L., Chandrasekpharappa, S. C., Marx, S. J., Spiegel, A. M., and Collins, F. S. (2003). Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol Cell Biol 23, 6075-85.
14. Davidson, W. F., Giese, T., and Fredrickson, T. N. (1998). Spontaneous development of plasmacytoid tumors in mice with defective Fas-Fas ligand interactions. J Exp Med 187, 1825-38.
15. Deng, C.-X. (2001). Tumorigenesis as a consequence of genetic instability in Brca1 mutant mice. Mutat Res 477, 183-89.
16. Deng, C.-X., Brodie, S. G. (2001). Knockout mouse models and mammary tumorigenesis. Cancer Biol 11, 387-94.
17. de Vries, A., van Oostrom, C. T. M., Dortant, P. M., Beems, R. B., van Kreijl, C. F., Capel, P. J. A., and van Steeg, H. (1997). Spontaneous liver tumors and benzo[α]pyrene-induced lymphomas in XPA-deficient mice. Mol Carcinog 19, 46-53.
18. de Vries, A., van Oostrom, C. T., Hofhuis, F. M., Dortant, P. M., Berg, R. J., de Gruijl, F. R., Wester, P. W., van Kreijl, C. F., Capel, P. J., van Steeg, H., et al. (1995). Increased susceptibility to ultraviolet-B and carcinogens of mice lacking the DNA excision repair gene XPA. Nature 377, 169-73.
19. de Vries, A., and van Steeg, H. (1996). Xpa knockout mice. Cancer Biol 7, 229-40.
20. de Wind, N., Dekker, M., Berns, A., Radman, M., and te Riele, H. (1995). Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82, 321-30.
21. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, Jr., C. A., Butel, J. S., and Bradley, A. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-21.
22. Donehower, L. A., Harvey, M., Vogel, H., McArthur, M. J., Montgomery, Jr., C. A., Park, S. H., Thompson, T., Ford, R. J., and Bradley, A. (1995). Effects of genetic background on tumorigenesis in p53-deficient mice. Mol Carcinog 14, 16-22.
23. Edelmann, W., Umar, A., Yang, K., Heyer, J., Kucherlapati, M., Lia, M., Kneitz, B., Avdievich, E., Fan, K., Wong, E., Crouse, G., Kunkel, T., Lipkin, M., Kolodner, R. D., and Kucherlapati, R. (2000). The DNA mismatch repair genes Msh3 and Msh6 cooperate in intestinal tumor suppression. Cancer Res 60, 803-7.
24. Edelmann, W., Yang, K., Kuraguchi, M., Heyer, J., Lia, M., Kneitz, B., Fan, K., Brown, A. M. C., Lipkin, M., and Kucherlapati, R. (1999). Tumorigenesis in Mlh1 and Mlh1/Apc1638N mutant mice. Cancer Res 59, 1301-7.
25. Fearon, E. R., and Gruber, S. B. (2001). Molecular abnormalities in colon and rectal cancer. In The Molecular Basis of Cancer, second edition (Mendelsohn, J., Howley, P. M., Israel, M. A., Liotta, L. A., eds.), pp. 289-312. Phila: WB Saunders Co.
26. Fitzpatrick, G. V., Soloway, P. D., and Higgins, M. J. (2002). Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1. Nature Genet 32, 426-31.
27. French, J., Storer, R. D., and Donehower, L. A. (2001). The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens. Toxicol Pathol 29, 24-9.
28. Ghebranious, N., and Donehower, L. A. (1998). Mouse models in tumor suppression. Oncogene 17, 3385-3400.
29. Giovannini, M., Robanus-Maandag, E., Niwa-Kawakita, M., van der Valk, M., Woodruff J. M., Goutebroze, L., Merel, P., Berns, A., and Thomas, G. (1999). Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev 13, 978-86.
30. Giovannini, M., Robanus-Maandag, E., van der Valk, M., Niwa-Kawakita, M., Abramowski, V., Goutebroze, L., Woodruff, J. M., Berns, A., and Thomas, G. (2000). Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 14, 1617-30.
31. Girnun, G. D., Smith, W. M., Drori, S., Sarraf, P., Mueller, E., Eng, C., Nambiar, P., Rosenberg, D. W., Bronson, R. T., Edelmann, W., Kucherlapati, R., Gonzalez, F. J., and Spiegelman, B. M. (2002). APC-dependent suppression of colon carcinogenesis by PPARγ. Proc Natl Acad Sci USA 99, 13771-6.
32. Goodrich, L. V., Milenkovic, L., Higgins, K. M., and Scott, M. P. (1997). Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109-13.
33. Guru, S. C., Crabtree, J. S., Brown, K. D., Dunn, K. J., Manickam, P., Prasad, N. B., Wangsa, D., Burns, A. L., Spiegel, A. M., Marx, S. J., Pavan, W. J., Collins, F. S., and Chandrasekharappa, S. C. (1999). Isolation, genomic organization, and expression analysis of Men1, the murine homolog of the MEN1 gene. Mamm Genome 10, 592-6.
34. Haase, V. H., Glickman, J. N., Socolovsky, M., and Jaenisch, R. (2001). Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor. Proc Natl Acad Sci USA 98, 1583-8.
35. Harvey, M., McArthur, M. J., Montgomery, Jr., C. A., Bradley, A., and Donehower, L. A. (1993). Genetic background alters the spectrum of tumors that develop in p53-deficient mice. FASEB J 7, 938-43.
36. Herzer, U., Crocoll, A., Barton, D., Howells, N., and Englert, C. (1999). The Wilms tumor suppressor gene wt1 is required for the development of the spleen. Curr Biol 9, 837-40.
37. Heyer, J., Yang, K., Lipkin, M., Edelmann, W., and Kucherlapati, R. (1999). Mouse models for colorectal cancer. Oncogene 18, 5325-33.
38. Δ20/+ mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9, 1021-7.
39. Hursting, S. D., Perkins, S. N., Phang, J. M., and Barrett, J. C. (2001). Diet and cancer prevention studies in p53-deficient mice. J Nutr 131, 3092S-4S.
40. Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., and Weinberg, R. A. (1992). Effects of an Rb mutation in the mouse. Nature 359, 295-300.
41. Jacks, T., Shih, T. S., Schmitt, E. M., Bronson, R. T., Bernards, A., and Weinberg, R. A. (1994). Tumor predisposition in mice heterozygous for a targeted mutation in Nf1 Nat Genet 7, 353-451.
42. Jacoby, R. F., Seibert, K., Cole, C. E., Kelloff, G., and Lubet, R. A. (2000). The cyclooxygenase-2 inhibbitor Celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res 60, 5040-4.
43. Jishage, K., Nezu, J., Kawase, Y., Iwata, T., Watanabe, M., Miyoshi, A., Ose, A., Habu, K., Kake, T., Kamada, N., Ueda, O., Kinoshita, M., Jenne, DE., Shimane, M., and Suzuki, H. (2002). Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proc Natl Acad Sci USA 99, 8903-8.
44. Kalamarides, M., Niwa-Kawakita, M., Leblois, H., Abramowski, V., Perricaudet, M., Janin, A., Thomas, G., Gutmann, D. H., and Giovannini, M. (2002). Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. Genes Dev 16, 1060-5.
45. Kreidberg, J. A., Sariola, H., Loring, J. M., Maeda, M., Pelletier, J., Housman, D., and Jaenisch, R. (1993). WT-1 is required for early kidney development. Cell 74, 679-91.
46. Kucherlapati, R., Lin, D. P., and Edelmann, W. (2001). Mouse models for human familial adenomatous polyposis. Cancer Biol 11, 219-25.
47. Kuperwasser, C., Hurlbut, G. D., Kittrell, F. S., Dickinson, E. S., Laucirica, R., Medina, D., Naber, S. P., and Jerry, D. J. (2000). Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome. Am J Pathol 157, 2151-9.
48. Kwiatkowski, D. J., Zhang, H., Bandura, J. L., Heiberger, K. M., Glogauer, M., el-Hashemite, N., and Onda, H. (2002). A mouse model of TSC1 reveals sex-dependent lethality from liver hemangiomas, and up-regulation of p70S6 kinase activity in Tsc1 null cells. Hum Mol Genet 11, 525-34.
49. Kwon, C.-H., Zhu, X., Zhang, J., Knoop, L. L., Tharp, R., Smeyne, R. J., Eberhart, C. G., Burger, P. C., and Baker, S. J. (2001). Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29, 404-11.
50. Largaespada, D. A., Brannan, C. I., Jenkins, N. A., and Copeland, N. G. (1996). Nf1 deficiency causes Ras-mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia. Nat Genet 12, 137-43.
51. Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., and Bradley, A. (1992). Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-94.
52. Li, G., Robinson, G. W., Lesche, R., Martinez-Diaz, H., Jiang, Z., Rozengurt, N., Wagner, K.-U., Wu, D.-C., Lane, T. F., Liu, X., Hennighausen, L., and Wu, H. (2002). Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129, 4159-70.
53. Lombard, D. D., Beard, C., Johnson, B., Marciniak, R. A., Dausman, J., Bronson, R., Buhlmann, J. E., Lipman, R., Curry, R., Sharpe, A., Jaenisch, R., and Guarente, L. (2000). Mutations in the WRN gene in mice accelerate mortality in a p53-null background. Mol Cell Biol 20, 3286-91.
54. Ludwig, T., Chapman, D. L., Papaioannou, V. E., and Efstratiadis, A. (1997). Targeted mutations of breast cancer susceptibility gene homologs I mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos. Genes Dev 11, 1226-41.
55. Ludwig, T., Fisher, P., Ganesan, S., and Efstratiadis, A. (2001). Tumorigenesis in mice carrying a truncating Brca1 mutation. Genes Dev 15, 1188-93.
56. Ludwig, T., Fisher, P., Murty, V., and Efstratiadis, A. (2001). Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice. Oncogene 20, 3937-48.
57. Luo, G., Santoro, I. M., McDaniel, L. D., Nishijima, I., Mills, M., Youssoufian, H., Vogel, H., Schultz, R. A., and Bradley, A. (2000). Cancer predisposition caused by elevated mitotic recombination in Bloom mice. Nat Genet 26, 424-9.
58. Lynch, H. T., and de la Chapelle, A. (2003). Hereditary colorectal cancer. N Engl J Med 348, 919-32.
59. Ma, W., Tessarollo, L., Hong, S.-B., Baba, M., Southon, E., Back, T. C., Spence, A., Lobe, C. G., Sharma, N., Maher, G. W., Pack, S., Vortmeyer, A. O., Guo, C., Zbar, B., and Schmidt, L. S. (2003). Hepatic vascular tumors, angiectasis in multiple organs and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. Cancer Res 63, 5320-28.
60. MacPherson, D., Sage, J., Crowley, D., Trumpp, A., Bronson, R. T., and Jacks, T. (2003). Conditional mutation of Rb causes cell cycle defects without apoptosis in the central nervous system. Mol Cell Biol 23, 1044-53.
61. Min mice through different mechanisms. Cancer Res 63, 1752-5.
62. Marino, S., Krimpenfort, P., Leung, C., van der Korput, H. A. G. M., Trapman, J., Camenisch. I., Berns, A., and Brandner, S. (2002). PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development 129, 3513-22.
63. McAllister, K. A., Bennett, L. M., Houle, C. D., Ward, T., Malphurs, J., Collins, N. K., Cachafeiro, C., Haseman, J., Goulding, E. H., Bunch, D., Eddy, E. M., Davis, B. J., and Wiseman, R. W. (2002). Cancer susceptibility of mice with a homozygous deletion in the COOH-terminal domain of the Brca2 gene. Cancer Res 62, 990-4.
64. McClatchey, A. I., Saotome, I., Mercer, K., Crowley, D., Gusella, J. F., Bronson, R. T., Jacks, T. (1998). Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev 12, 1121-33.
65. McClatchey, A. I., Saotome, I., Ramesh, V., Gusella, J. F., and Jacks, T. (1997). The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes Dev 11, 1253-65.
66. Mendelsohn, J. (Ed) (2001). The Molecular Basis Of Cancer, Second edition, Philadelphia, Saunders, 691 p.
67. Miyoshi, H., Nakau, M., Ishikawa, T. O., Seldin, MF., Oshima, M., and Taketo, M. M. (2002). Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice. Cancer Res 62, 2261-6.
68. Moynahan, M. E. (2002). The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans. Oncogene 21, 8994-9007.
69. Nakane, H., Takeuchi, S., Yuba, S., Saijo, M., Nakatsu, Y., Murai, H., Nakatsuru, Y., Ishikawa, T., Hirota, S., Kitamura, Y., Kato, Y., Tsunoda, Y., Miyauchi, H., Hrio, T., Tokunaga, T., Matsunaga, T., Nikaido, O., Nishimune, Y., Okada, Y., Tanaka, K., et al. (1995). High incidence of ultraviolet-B-or chemical-carcinogen-induced skin tumours in mice lacking the xeroderma pigmentosum group A gene. Nature 377, 165-8.
70. Nakau, M., Miyoshi, H., Seldin, M. F., Imamura, M., Oshima, M., and Taketo, M. M. (2002) Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res 62, 4549-53.
71. +/- mice. Proc Natl Acad Sci USA 96, 3916-21.
72. +/- mice. Genes Dev 10, 1870-9.
73. +/- mice. Cancer Res 62, 5134-8.
74. Nussbaum, R. L., McInnes, R. R., and Willard, H. F. (2001). Thompson & Thompson Genetics in Medicine, 6th Edition. W.B. Saunders, Philadelphia, 444 pp.
75. +/- mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest 104, 687-95.
76. Min mouse: down regulation of beta-catenin signaling by a combination of tea plus sulindac. Carcinogenesis 24, 263-7.
77. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-9.
78. Phillips, R. K. S., Wallace, M. H., Lynch, P. M., Hawk, E., Gordon, G. B., Saunders, B. P., Wakabayashi, N., Shen, Y., Zimmerman, S., Godio, L., Rodriguez-Bigas, M., Su, L.-K., Sherman, J., Kelloff, G., Levin, B., and Steinbach, G. (2002). A randomized, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 50, 857-60.
79. Podsypanina, K., Ellenson, L. H., Nemes, A., Gu, J., Tamura, M., Yamada, K. M., Cordon-Cardo, C., Catoretti, G., Fisher, P. E., and Parsons, R. (1999). Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96, 1563-8.
80. Purdie, C. A., Harrison, D. J., Peter, A., Dobbie, L., White, S., Howie, S. E. M., Salter, D. M., Bird, C. C., Wyllie, A. H., Hooper, M. L., and Clarke, A. R. (1994). Tumor incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9, 603-9.
81. Reitmair, A. H., Schmits, R., Ewel, A., Bapat, B., Redston, M., Mitri, A., Waterhouse, P., Mittrucker, H.-W., Wakeham, A., Liu, B., Thomason, A., Griesser, H., Gallinger, S., Ballhausen, W. G., Fishel, R., and Mak, T. W. (1995). MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 11, 64-70.
82. +/- mice. Nat Med 2, 1316-21.
83. Seno, H., Oshima, M., Ishikawa, T. O., Oshima, H., Takaku, K., Chiba, T., Narumiya, S., and Taketo, M. M. (2002). Cyclooxygenase2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res 62, 506-11.
84. Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., and De-Pinho, R. A. (1996). Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27-37.
85. +/- mice. Carcinogenesis 24, 179-83.
86. INK4a and p53 deficiency cooperate in tumorigenesis. Cancer Res 62, 2761-5.
87. Spring, K., Ahangari, F., Scott, S. P., Waring, P., Purdie, D. M., Chen, P. C., Hourigan, K., Ramsay, J., McKinnon, P. J., Swift, M., and Lavin, M. F. (2002). Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat Genet 32, 185-90.
88. Spring, K., Cross, S., Li, C., Watters, D., Ben-Senior, L., Waring, P., Ahangari, F., Lu, S., Chen, P., Misko, I., Paterson, C., Kay, G., Smorodinsky, N. I., Shiloh, Y., and Lavin, M. F. (2001). Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res 61, 4561-8.
89. Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., and Dove, W. F. (1992). Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-70.
90. Suzuki, A., Itami, S., Ohishi, M., Hamada, K., Inoue, T., Komazawa, N., Senoo, H., Sasaki, T., Takeda, J., Manabe, M., Mak, T. W., and Nakano, T. (2003). Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation. Cancer Res 63, 674-81.
91. Tonelli, F., Valanzano, R., Messerini, L., and Ficari, F. (2000). Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer? J Surg Oncol 74, 15-20.
92. Uhlmann, E. J., Apicelli, A. J., Baldwin, R. L., Burke, S. P., Bajenaru, M. L., Onda, H., Kwiatkowski, D., and Gutmann, D. H. (2002). Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells. Oncogene 21, 4050-9.
93. Vogel, K. S., Klesse, L. J., Velasco-Miguel, S., Meyers, K., Rushing, E. J., and Parada, L. F. (1999). Mouse tumor model for neurofibromatosis Type 1. Science 286, 2176-9.
94. Vogelstein, B., and Kinzler, K. W. (eds.) (2002). The Genetic Basis of Human Cancer, 2nd Edn. New York, McGraw-Hill, 821 p.
95. Vooijs, M., and Berns, A. (1999). Developmental defects and tumor predisposition in Rb mutant mice. Oncogene 18, 5293-303.
96. Wagner, K. D., Wagner, N., Vidal, V. P., Schley, G., Wilhelm, D., Schedl, A., Englert, C., and Scholz, H. (2002). The Wilms' tumor gene Wt1 is required for normal development of the retina. EMBO J 21, 1398-1405.
97. Wang, H., Douglas, W., Lia, M., Edelmann, W., Kucherlapati, R., Podsypanina, K., Parsons, R., and Ellenson, L. H. (2002). DNA mismatch repair deficiency accelerates endometrial tumorigenesis in Pten heterozygous mice. Am J Pathol 160, 1481-6.
98. Ward, J. M. (2002). Preneoplastic and precancerous lesions in rodents: morphologic and molecular characteristics. J Toxicol Pathol 15, 123-8.
99. Wei, K., Kucherlapati, R., and Edelmann, W. (2002). Mouse models for human DNA mismatch-repair gene defects. Trends Molec Med 8, 346-53.
100. Williams, B. O., Remington, L., Albert, D. M., Mukai, S., Bronson, R. T., and Jacks, T. (1994). Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7, 480-4.
101. Yang, Y., Kuang, Y., De Oca, R. M., Hays, T., Moreau, L., Lu, N., Seed, B., and D'Andrea, A. D. (2001). Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood 98, 3435-40.
102. Zbar, B., Klausner, R., and Linehan, WM. (2003). Studying cancer families to identify kidney cancer genes. Annu Rev Med 54, 217-33.
103. Zhu, Y., and Parada, L. F. (2002). The molecular and genetic basis of neurological tumours. Nature 2, 616-26.
104. Zhu, Y., Ghosh, P., Charnay, P., Burns, D. K., and Parada, L. F. (2002). Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 296, 920-2.
105. Zurawel, R. H., Allen, C., Wechsler-Reya, R., Scott, M. P., and Raffel, C. (2000). Evidence that haploinsufficiency of Ptch leads to medulloblastoma in mice. Genes Chromosomes Cancer 28, 77-81.